1 Teng, W, Shan, Z, Teng, X, et al. (2006) Effect of iodine intake on thyroid diseases in China. N Engl J Med 354, 2783–2793.
2 Shan, Z, Teng, W, Li, Y, et al. (2001) Comparative epidemiological study on the prevalence of iodine-induced hypothyroidism. Chin J Endocrinol Metab 7, 71–74.
3 Gurr, JA & Kourides, IA (1983) Regulation of thyrotropin biosynthesis. Discordant effect of thyroid hormone on alpha and beta subunit mRNA levels. J Biol Chem 258, 10 208–10 211.
4 Shupnik, MA, Chin, WW, Habener, JF, et al. (1985) Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem 260, 2900–2903.
5 Schröder-van der Elst, JP, van der Heide, D, Morreale de Escobar, G, et al. (1998) Iodothyronine deiodinase activities in fetal rat tissues at several levels of iodine deficiency: a role for the skin in 3,5,3′-triiodothyronine economy. Endocrinology 139, 2229–2234.
6 Salvatore, D, Tu, H, Harney, JW, et al. (1996) Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98, 962–968.
7 Murakami, M, Araki, O, Hosoi, Y, et al. (2001) Expression and regulation of type II iodothyronine deiodinase in human thyroid gland. Endocrinology 142, 2961–2967.
8 Imai, Y, Toyoda, N, Maeda, A, et al. (2001) Type 2 iodothyronine deiodinase expression is upregulated by the protein kinase A-dependent pathway and is downregulated by the protein kinase C-dependent pathway in cultured human thyroid cells. Thyroid 11, 899–907.
9 Croteau, W, Davey, JC, Galton, VA, et al. (1996) Cloning of the mammalian type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98, 405–417.
10 Hosoi, Y, Murakami, M, Mizuma, H, et al. (1999) Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J Clin Endocrinol Metab 84, 3293–3300.
11 Dentice, M, Morisco, C, Vitale, M, et al. (2003) The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2·5 and GATA-4 transcription factors. Mol Endocrinol 17, 1508–1521.
12 Kuiper, GG, Kester, MH, Peeters, RP, et al. (2005) Biochemical mechanisms of thyroid hormone deiodination. Thyroid 15, 787–798.
13 Bianco, AC, Salvatore, D, Gereben, B, et al. (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23, 38–89.
14 Bianco, AC & Silva, JE (1987) Nuclear 3,5,3′-triiodothyronine (T3) in brown adipose tissue: receptor occupancy and sources of T3 as determined by in vivo techniques. Endocrinology 120, 55–62.
15 Silva, JE & Larsen, PR (1978) Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats: further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. J Clin Invest 61, 1247–1259.
16 Silva, JE, Dick, TE & Larsen, PR (1978) The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3′-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology 103, 1196–1207.
17 Yen, PM, Sunday, ME, Darling, DS, et al. (1992) Isoform-specific thyroid hormone receptor antibodies detect multiple thyroid hormone receptors in rat and human pituitaries. Endocrinology 130, 1539–1546.
18 Childs, GV, Taub, K, Jones, KE, et al. (1991) Triiodothyronine receptor beta-2 messenger ribonucleic acid expression by somatotropes and thyrotropes: effect of propylthiouracil-induced hypothyroidism in rats. Endocrinology 129, 2767–2773.
19 Fliers, E, Unmehopa, UA & Alkemade, A (2006) Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland. Mol Cell Endocrinol 251, 1–8.
20 Friesema, EC, Ganguly, S, Abdalla, A, et al. (2003) Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278, 40128–40135.
21 Diano, S, Naftolin, F, Goglia, F, et al. (1998) Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus. Endocrinology 139, 2879–2884.
22 Gereben, B, Zavacki, AM, Ribich, S, et al. (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29, 898–938.
23 Smerdely, P, Pitsiavas, V & Boyages, SC (1993) Evidence that the inhibitory effects of iodide on thyroid cell proliferation are due to arrest of the cell cycle at G0G1 and G2M phases. Endocrinology 133, 2881–2888.
24 Alkemade, A, Friesema, EC, Kuiper, GG, et al. (2006) Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. Eur J Endocrinol 154, 491–500.
25 Christoffolete, MA, Ribeiro, R, Singru, P, et al. (2006) Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology 147, 1735–1743.
26 St. Germain, DL & Galton, VA (1997) The deiodinase family of selenoproteins. Thyroid 7, 655–668.
27 Obregón, MJ, Ruiz de Oña, C, Calvo, R, et al. (1991) Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology 129, 2663–2673.
28 Janssen, KP, Van Der Heide, D, Visser, TJ, et al. (1994) Thyroid function and deiodinase activities in rats with marginal iodine deficiency. Biol Trace Element Res 40, 237–246.
29 Meinhold, H, Campos-Barros, A, Walzog, B, et al. (1993) Effects of selenium and iodine deficiency on type I, type II and type III iodothyronine deiodinases and circulating thyroid hormones in the rat. Exp Clin Endocrinol 101, 87–93.
30 Mitchell, JH, Nicol, F, Beckett, GJ, et al. (1997) Selenium and iodine deficiencies: effects on brain and brown adipose tissue selenoenzyme activity and expression. J Endocrinol 155, 255–263.
31 Pazos-Moura, CC, Moura, EG, Dorris, ML, et al. (1991) Effect of iodine deficiency and cold exposure on thyroxine 5′-deiodinase activity in various rat tissues. Am J Physiol 260, (2 Pt 1), E175–E182.
32 Perret, G, Yin, YL, Nicolas, P, et al. (1991) In vivo effects of macrolides on thyroid hormone serum levels and on hepatic type 1 5′-deiodinase in rat. A comparative study with amiodarone, phenobarbital and propranolol. Fundam Clin Pharmacol 5, 583–593.
33 Wang, K, Sun, YN, Liu, JY, et al. (2006) Type 1 iodothyronine deiodinase activity and mRNA expression in rat thyroid tissue with different iodine intakes. Chin Med J (Engl) 119, 1899–1903.
34 Bednarczuk, T, Pietrzykowski, A, Słoń, M, et al. (1993) Pharmacologic effect of excess iodine on type I thyroxine 5′-deiodinase activity in rat thyroid. Endokrynol Pol 44, 405–412.
35 Aanderud, S, Sundsfjord, J & Aarbakke, J (1984) Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes. Endocrinology 115, 1605–1608.
36 Safran, M, Fang, SL, Bambini, G, et al. (1986) Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat. Am J Med Sci 292, 136–141.
37 Rosene, ML, Wittmann, G, Arrojo e Drigo, R, et al. (2010) Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment. Endocrinology 151, 5961–5970.
38 Tu, HM, Kim, SW, Salvatore, D, et al. (1997) Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138, 3359–3368.
39 Burmeister, LA, Pachucki, J & St. Germain, DL (1997) Thyroid hormones inhibit type 2 iodothyronine deiodinase in rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138, 5231–5237.
40 Kim, SW, Harney, JW & Larsen, PR (1998) Studies of the hormonal regulation of type 2 5′iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 139, 4895–4905.
41 Abel, ED, Boers, ME, Pazos-Moura, C, et al. (1999) Divergent roles for TH receptor beta isoforms in the endocrine axis and auditory system. J Clin Invest 104, 291–300.
42 Kratzsch, J, FiedlerG, M, Leichtle, A, et al. (2005) Newer reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 51, 1480–1486.
43 Elmlinger, MW, Dengler, T, Weinstock, C, et al. (2003) Endocrine alterations in the aging male. Clin Chem Lab Med 41, 934–941.
44 Boucai, L & Surks, MI (2009) Reference limits of serum thyrotropin (TSH) and free thyroxine (Free T4) are significantly influenced by race and age in an urban outpatient practice of medicine. Clin Endocrinol (Oxf) 70, 788–793.
45 Surks, MI & Hollowell, JG (2007) Age-specific distribution of serum thyrotropin andantithyroid antibodies in the U.S. population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92, 4575–4582.
46 Guan, H, Shan, Z, Teng, X, et al. (2008) Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf) 69, 136–141.
47 Pekary, AE, Hershman, JM, Sugawara, M, et al. (1983) Preferential release of triiodothyronine: an intrathyroidal adaptation to reduced serum thyroxine in ageing rats. J Gerontol 38, 653–659.
48 Co'nsole, GM, Go'mez-Dumm, CL & Goya, RG (1995) Immunohistochemical and radioimmunological assessment of thyrotrophs in the pituitary of ageing rats. Acta Anat (Basel) 152, 28–32.
49 Moreira, DG, Marassi, MP, Corrêa da Costa, VM, et al. (2005) Effects of ageing and pharmacological hypothyroidism on pituitary-thyroid axis of Dutch-Miranda and Wistar rats. Exp Gerontol 40, 330–334.